Cargando…
Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma
PURPOSE: The aim of the study is to investigate the prognostic value of plasma interleukin-35 in the surgical treatment of patients with clear cell renal cell carcinoma (ccRCC). Material and Methods. Plasma IL-35 levels were measured in patients with ccRCC. The cut-off value of IL-35 was determined...
Autores principales: | Zhang, Jun, Xu, Xiaojian, Chen, Zongxin, Zhu, Zhengyu, Hou, Jianquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482474/ https://www.ncbi.nlm.nih.gov/pubmed/36124013 http://dx.doi.org/10.1155/2022/6886590 |
Ejemplares similares
-
Retracted: Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Importance of metabolic and immune profile as a prognostic indicator in patients with diabetic clear cell renal cell carcinoma
por: Cheng, Xiangyu, et al.
Publicado: (2023) -
High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma
por: Pan, Deng, et al.
Publicado: (2015) -
Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: Ha, U-Syn, et al.
Publicado: (2018) -
Combination of Hematology Indicators and Oncological Characteristics as a New Promising Prognostic Factor in Localized Clear Cell Renal Cell Carcinoma
por: Kang, Xiangpeng, et al.
Publicado: (2020)